BeiGene, Ltd. (BEIGF)
OTCMKTS
· Delayed Price · Currency is USD
15.50
0.00 (0.00%)
At close: Sep 3, 2024
BeiGene Market Cap
BeiGene has a market cap or net worth of $21.52 billion as of October 31, 2024. Its market cap has increased by 18.49% in one year.
Market Cap
21.52B
Enterprise Value
20.02B
Revenue
3.10B
Ranking
n/a
PE Ratio
n/a
Stock Price
$15.50
Market Cap Chart
Since February 3, 2016, BeiGene's market cap has increased from 858.74M to 21.52B, an increase of 2,406.00%. That is a compound annual growth rate of 44.53%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sandoz Group AG | 18.88B |
Telix Pharmaceuticals Limited | 4.63B |
Elekta AB (publ) | 2.39B |
Ryman Healthcare Limited | 2.04B |
Verano Holdings Corp. | 1.19B |
Vireo Growth Inc. | 95.99M |
Medexus Pharmaceuticals Inc. | 45.71M |